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Summary 
It has been over 50 years since Dr Leo Kanner first wrote and published his 
paper applying the term autism to a group of children who were self-absorbed 
and who had severe social, communication and behavioural problems. Since 
then, research into autism and subsequently, ASDs, has increased by significant 
leaps and bounds. The vaccination argument has been debunked, but not 
completely eradicated from societal thinking, and scientists and psychologists 
alike agree that both “nature and nurture” affect an individual’s predisposition 
to having autism. This work will look at some of the advances made in autism 
research, demonstrating this by using traditional genetic techniques, as well as 
more modern, computerized procedures. Furthermore, the use of investigative 
cohort studies look at the prevalence of autism in the South African perspective, 
with the aim of increasing genetic data relevant to this region.  
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Autism, Aspergers Syndrome and Pervasive Developmental Delay-Not Otherwise Specified 
(PDD-NOS), among others, fall under an umbrella of disorders known as Autism Spectrum 
Disorder. Twin studies show that autism is a highly heritable disorder. More than 100 genes 
have been implicated in the aetiology of autism, each of which is involved in numerous 
biological processes and a variety of molecular interactions. William-Beuren syndrome is a 
multisystem developmental disorder caused by the deletion of contiguous genes at the 
7q11.23 position. The aims of this study were (i) to genotype three SNPs (rs10279013, 
rs2293484 and rs17060) in the ABHD11 and ABCA13 genes, respectively, using Taqman® 
SNP Genotyping assays to detect association with autism in three distinct South African (SA) 
ethnic groups (Black, Caucasian and Mixed), and (ii) to ascertain common pathways or 
regulating transcription factors for genes on chromosome 7 that may attribute to it being an 
“autism hotspot”. Chapter 3 objectives were to identify potential candidate genes using 
STRING analysis and the GeneCards database. The Taqman® study indicated significant 
association for SNP rs2293484 in the South African Caucasian group, as well as for the G 
allele in the South African Mixed group, where p<0.001. STRING analysis yielded 2 new 
candidate genes, FZD1 and FZD9. It was also found that the Wnt pathway in mammals plays 
a significant role in both ASDs and cancer, and there is a definite link between genes 
regulating cancer, and genes implicated in autism. The study provides evidence for not only 
the association of the investigated SNP in a South African population, but also provides 
evidence for the co-morbidity of several neurological and psychological disorders such as 
depression and bipolar disorder with autism 
Keywords: autism, bioinformatics, candidate genes, chromosome 7, ABCA13, ABHD11, 
FZD1, FZD9, SNPs, genotyping , William-Beuren Syndrome, transcription factors 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1. A history of autism 
 
Eugene Bleuler first used the term autism around 1911 to describe patients with 
schizophrenia. The autistic disorder, or classic autism was first described over sixty years ago 
by Dr Leo Kanner of the Johns Hopkins University in the U.S.A. Around the same a time, a 
Swiss psychiatrist, Dr Hans Asperger described a milder form of the disorder, characterised 
by higher cognitive abilities and better language function (Wolff, 2004). 
Autism and schizophrenia were linked in many researchers’ minds until the 1960’s. It was 
only during this time, after Dr. Kanner’s descriptions that medical professionals would make 
the differentiation between the two disorders, especially in children (Schanen, 2006). Early 
treatment for autism was largely focused on medication such as LSD, as well as electric 
shock therapy and behavioural change techniques that were based on pain and punishment. 
Early intervention and unique, specialized treatments are the basis for modern-day treatment 
of autism and Autism Spectrum Disorders (ASDs) (Autism Speaks, 2013).  Depending on the 
severity of the disorder in the child, treatment is behaviour-based, medication-based, or both. 
Many individuals with autism have additional conditions and disorders such as sleeping 
disorders, aggression, seizures, epilepsy and gastrointestinal distress, as well as Down’s 
syndrome, Tourette’s syndrome, Fragile-X syndrome (Piven and Palmer, 1999 and Schanen 
2006). The latter disorders mentioned all have clearly defined genetic links as their causes, 
and this has lead researchers to look at autism as a genetic disorder, in order to find a 
causative factor. 
 
While there is now considerable evidence to support genetic factors in the aetiology of autism, 
there is still no definitive causative factor. Since the landmark twin study by Folstein and 
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Rutter (1977) indicating the strong genetic link between the inheritance of autism between 
identical and fraternal twins, researchers have made leaps and bounds in the study of genetic 
factors influencing autism, as well as co-morbid disorders in individuals. Several ‘candidate 
genes’ have been identified, most of them being found to have a positive association to 
autism in specific population groups. Extensive single nucleotide polymorphism (SNP) 
studies have been done and are underway (Prasad et al., 2013; Polumbo et al., 2013; Arieff et 
al., 2010) in order to glean the extent of DNA mutations present in specific population groups 
with regards to autism (Sharma et al., 2013), as well as microarray studies (Gameeldien 2009) 
to research the prevalence of over- and under-expressed genes in a specific population.                                                    
Computational analysis and bioinformatics in genetic studies has also proven to be an 
invaluable research tool. Data-intensive research has been made simpler in terms of analysis 
and database maintenance (Perez-Iratxeta et al., 2007). One of the important and extremely 
useful roles these types of programs play in biological studies is that they are able to organize 
genes and proteins within their larger biological context. This includes identifying common 
pathways and protein interactions of various genes and proteins in different biological 
functions (Romero et al., 2004). 
The study of the genetics of autism worldwide has yielded an overwhelming amount of 
information, particularly pertaining to candidate genes being identified for their various roles 
in the vastly differentiated symptoms of autism and ASDs (ASDs) (Lord, 2011). 
Bioinformatics and computational analysis allows researchers to streamline all of this 
information into a single database of their choice and further investigate the interactions of 
proteins and genes at the molecular pathway level. Pretorius et al. (2011) describes a detailed 
methodology for the functional analysis and characterization of the human Retinoblastoma 
Binding Protein 6 (RBBP6) promoters using a combination of molecular biology as well as 
computational analysis. Their study found that the RBBP6 gene, although already linked to 
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apoptosis and cancer, also showed links with diabetes and Alzheimer’s disease. 
Zeidán-Chuliá et al. (2013) used a systematic computer-based approach to identify the major 
biological processes and cellular components molecular functions that are crucial to autism, 
while at the same time ascertaining the most essential contributions (genetic and/or 
environmental) in silico (Zeidán-Chuliá et al., 2013).  Their research identified that the genes 
Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1) and the Rhodopsin (RHO) family of 
GTPases could play a critical role in the neuropathological events associated with autism. 
The structure of this work will be based on both a molecular and computational approach for 
looking at implicated genes in autism and ASDs in the South African population. Two genes 
have been identified by a previous study (Gameeldien, 2009) as important under- and over-
expressed in the population, and this study will aim to look at the allelic frequency of SNPs in 
the population as well as the computational analysis of why chromosome 7 has been 
implicated as an ‘autism hotspot’ by looking at the molecular pathways within genes 
implicated in autism. 
 
1.2. Autism 
 
Autism, Aspergers Syndrome and Pervasive Developmental Delay-Not Otherwise Specified 
(PDD-NOS), among others, fall under an umbrella of disorders known as Autism Spectrum 
Disorder (Volkmar and Rutter, 1995; Volkmar et al., 1997). ASDs are neurodevelopmental 
disorders that are characterized and diagnosed by very specific behaviours - impaired social 
interaction, impaired communication and restrictive or repetitive interests or behaviours 
(Benayed et al., 2004). The autistic phenotype is a behaviour-based syndrome described by 
the DSM-V (American Psychiatric Association, 2014). The DSM-V (Diagnostic and 
Statistical Manual of Mental Disorders) provides a classification of mental disorder, written 
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in common language with standard criteria. It is widely used in the United States and also 
around the world. It is utilized by a number of various health professionals, as well as persons 
involved in the health industry (pharmaceutics, researchers, health insurance companies, 
policy makers) for diagnosis and decisions regarding mental health issues. 
 
Autistic disorder is diagnosed with the presence of six symptoms in total; these include at 
least two symptoms of impairment in social interaction, at least one symptom of impaired 
communication skills, and at least one symptom of restrictive and repetitive behaviour, 
illustrated in figure 1.1. (Lamb et al., 2000). Symptoms are typically displayed from 3 years 
of age, and may persist into adulthood. 
 
Figure 1.1: An example of the typical obsessive behaviour as a symptom of autism. 
(http://sandrarose.com/2012/02/medical-minute-autism/) 
Autism has been classified as the most frequently occurring of all childhood neurological 
disorders (Baio, 2012). The number of people known to have autism has increased 
dramatically since the 1980’s. Whether this is due to changes and advances in diagnostic 
practices or whether actual prevalence has increased is still a topic of intense scrutiny. In 
South Africa, there is currently no accessible database system that holds information as to the 
number of children affected in the population. One study indicates that the current global 
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incidence for autism and ASDs is 1 in 68 (Centre for Disease Control, 2015); affecting four 
times more males than females (Kopetz and Endowed, 2012). 
There is no conclusive evidence to point to the male-female ratio discrepancy, but several 
theories have been put forward and active investigative studies are underway to find answers. 
One school of thought suggests that it is the inherent behavioural differences in males and 
females that may contribute to the high male:female ratio. Females are largely, by nature, 
sociable. So it is a theory that because of this, female children will seem better adjusted; 
socially, than their male peers. Girls are often diagnosed with ASD at much later ages than 
boys. A more complex theory is that autism is X-linked. Evidence is emerging from studies in 
both humans and mice for a general influence on intelligence. There are a large number of 
mental disorders that are X-linked. In addition to this, studies also show that X-linked genes 
have specific effects on social-cognition and emotional development. It is proposed that 
because females have an extra X chromosome, it serves as a genetic 'protection' against the 
effects that have been attributed to X-linked disorders (Skuse 2005). 
In another study by Ptaff et al. (2011) they postulated that due to the higher testosterone 
levels (TST) in boys, higher amounts of arousal-related inputs to the amygdala sensitizes 
genetically vulnerable infants to very early stresses. Arousal-related inputs are known to 
prime amygdaloidal mechanisms for fear and anxiety, which may result in social avoidance. 
In contrast to boys, girls do not possess high levels of TST-facilitated arousal-causing inputs 
to the amygdala, and in addition to this, they have protection provided by oxytocin and its 
receptors. 
According to a recent study (Yang. et al., 2012) there may be two different neural pathways 
involved in boys and girls. They tested the genes contained in denovo copy number variations 
(CNVs) from boys and girls with ASD by a web database. Significantly different neural 
pathways were observed in both boys and girls, which was indicative of the role that different 
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combinations of genes play in these pathways, and are implicated in the number of girl 
affected, versus the number of boys. 
Though there has been an increasing incidence of autism, the causes of ASDs are still 
unknown; general consensus is that it is thought to be caused by a combination of both 
environmental and genetic factors. The study of identical and fraternal twins supports the 
argument for the heritability factor as aetiology for ASD. Epidemiological studies of autism 
report difficult pregnancies, viral infections, metabolic conditions and the ever-popular 
vaccine argument as causes of autistic disorder (St-Hilaire et al., 2012). It is therefore safe to 
draw the conclusion that both environment and genetics may contribute to the manifestation 
of autism in children (Rodier and Hyman, 1998). 
 
1.3. Environmental factors 
During the 1950s and 1960s it was well established that many infectious diseases were 
detrimental to the developing brain. Many of the causative factors of other diseases that 
caused mental retardation were then investigated as causative agents for autism. Pre-natal 
exposure to the rubella virus (Libbey et al., 2005) can cause birth defects including mental 
retardation, blindness, deafness and autism. Studies of large samples have shown the 
increased rate of autism in children who had been exposed to the rubella virus in utero 
(Sigman et al., 2006). A significantly controversial topic in the autism community is whether 
or not vaccines, particularly the measles, mumps and rubella (MMR) vaccine, can be blamed 
as a cause for autism. Up until 2001, sodium ethylmercurithiosalicylate, commonly known as 
thiomersal, was a mercury-based preservative that was frequently used in MMR vaccines 
(Kaye et al., 2001). Concern regarding the use of thiomersal was based on the fact that 
organic mercury has a negative effect on the developing brain and that children receiving 
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vaccinations were thus affected. There is currently no conclusive scientific evidence that 
positively links the effects of thiomersal to autism (Nelson and Bauman 2003; Peltola et al., 
1998). Despite the scientific evidence for MMR vaccinations not being a cause for autism, 
there are still an alarming number of people who refuse to have their children vaccinated. 
This “anti-vaxxer” movement is so large that in 2014, a measles outbreak occurred in the 
United States, thought to have originated from a Disneyland theme park (Centre for Disease 
Control, 2014). In 2014, a meta-analysis study (a cohort study involving 1 256 407 
experimental subjects and 9 920 control subjects) was published that showed no evidence for 
a link between autism and vaccines. The study showed statistical significance for no 
relationship between vaccines and autism, no relationship between autism/ASDs MMR, no 
relationship between autism/ASD and thiomersal and no relationship between autism/ASDs 
and mercury (Taylor et al., 2014).  
Other environmental factors that may influence the development of autism in an individual 
include the use of addictive substances such as alcohol and drugs during early gestation. 
Autism has been linked to foetal alcohol syndrome and disorders caused by addictive drugs 
such as cocaine and methamphetamines (Davis et al., 1992) and have consequently shown to 
affect brain development and function (Baird et al., 2003). Mercury exposure from sources 
such as diet (particularly in fish) and dental amalgam fillings have been implicated as causes 
of autism (Lawler et al., 2004). Methylmercury exposure in humans and the role of selenium 
as a factor which counteracts methylmercury toxicity and protects against some neurological 
effects of exposure has yielded information on its potential etiological factors in ASD (Mania 
et al., 2012). 
1.4. Genetic factors 
It is clear that autism is a highly heritable disorder, but the precise molecular agents 
responsible for the heritability of the disorder are still unknown. Evidence for genetics as a 
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contributing agent of the cause of autism is supplied by studies of autistic twins (Folstein and 
Rutter, 1977). Twin studies provide information on complex genetic interactions in 
individuals by comparing the genetic similarity of monozygotic (MZ) twins (identical), who 
share 100 percent of their genes, to dizygotic (DZ) twins (fraternal), who share only 50 
percent of their genes. The likelihood that the identical twin of an autistic child would also be 
autistic is approximately 82 percent, whereas the equivalent rate for DZ twins is around only 
10% (Bailey et al., 1995, Wall et al., 2008). These findings suggest that autism is under a 
high influence of genetic manipulation, with the involvement of multiple loci. 
It remains unclear whether the genetic component is a combination of a few common variants, 
or rare variants. More than 100 genes have been implicated in the aetiology of autism, each of 
which is involved in numerous biological processes and a variety of molecular interactions 
(Newschaffer et al., 2002; Phillippe et al., 2002). These processes include anything from 
brain development to speech (Wall et al., 2009). More than the specific genes, several 
chromosomal “hotspots” have been implicated in the aetiolgy of autism, with chromosome 7 
(Ashley-Koch et al., 1999) currently housing the largest number of genes found to be linked 
to autism (table 1). All other pervasive developmental disorders (PDDs), with the exception 
of Rett’s syndrome, have no monogenic link. Family studies and clinical reports indicate that 
there is significant overlap among the three most common PDDs; that is, Asperger’s disorder, 
autistic disorder and PDD-NOS. However, the magnitude of the overlap is inconclusive 
(Constantino and Todd, 2003). 
 
1.5. Autism as a neurological disorder 
Studies of brain structure have implicated several aspects of brain development as causative 
effects in the characteristic symptoms of autism and ASDs. These neuronal disturbances may 
 
 
 
 
 17 
lead to a range of abnormalities, including an increase in brain volume. Several studies have 
shown that the brain volume in children with autism is significantly larger than unaffected 
individuals (Hardan et al., 2000). Neuropathological studies have shown and reported an 
increase in brain weight in children affected with autism. 
Figure 1.2 shows an fMRI scan of the differences activation patterns in the brain in 
unaffected versus autistic children. Morphometric analysis of the brain has demonstrated 
enlargement of the hippocampus, and amygdala, as well as excessive growth in the 
cerebellum during early development (Kellerher and Bear, 2008). However, Harden et al. 
(2000) had reported these brain volumes and weight differences in childhood only, not in 
adults with autism. It is also well-documented that children with autism have been found to 
have larger heads than the general population (Aylward et al., 2002). Some studies have 
suggested that the larger brain includes a higher white matter volume, with disrupted grey 
matter cellular columns, which may contribute to the difficulties with information integration 
experienced by people with autism (Schultz et al., 2000). A study by neuroscientists at 
Columbia University Medical Centre suggests that children with autism have a surplus of 
synapses. The researchers say that the excess is due to a slowdown in the normal pruning 
process that occurs during brain development (Tang, et al., 2014). The study further showed 
that when applied to mouse-models, the pruning defect was found to be linked to a protein 
called mTOR. The researchers restored normal autophagy and synaptic pruning in the mice 
by administering rapamycin – a drug that inhibits mTOR. Treatment eliminated the mice’s 
autism-like behaviors. The treatment remained effective even when administered to older 
mice that had fully developed the autism-like behaviours. The researchers cite this as hopeful 
evidence that similar treatments might aid in treating autism symptoms.  
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Figure 1.2: fMRI of autism vs. healthy control activation pattern in the brain 
(http://www.apa.org/education/k12/brain-function.aspx?item=4#) 
 
1.6. Single Nucleotide Polymorphisms 
 
1.6.1. What are SNPs? 
 
Single nucleotide polymorphisms (SNPs) are the most frequently occurring type of variation 
in the human genome. This variation occurs when there is a significant frequency (>1%) of a 
single nucleotide difference in a DNA sequence between members of a species or between 
paired chromosomes in an individual (fig.1.3). SNPs provide geneticists with a powerful tool 
for the study of human medical genetics (Wang et al., 2008) 
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Figure 1.3: The most frequently occurring of all genetic variation, the single nucleotide polymorphism. 
(http://science.marshall.edu/murraye/341/Images/416px-Dna-SNP_svg.png) 
With the complete sequencing of the human genome in 2000, information about SNPs has 
become more accessible for public and research use (The International SNP Map Working 
Group, 2001). Databases have been set up on the internet such as the NCBI SNP database, the 
HapMap database and GeneCards, which offers valuable information such as SNP sequences, 
whether the SNP is intronic or exonic, what function and disease or disorder it is implicated 
or involved in and the gene it is found on. Various biotechnology companies offer services 
such as custom or ready-made SNPs (www.appliedbiosystems.com). To date, more than 1.42 
million SNPs have been identified in the human genome, the majority of which are publicly 
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available. SNPs have helped to identify genes that have been shown to be involved in a 
myriad of diseases and disorders, ranging from lifestyle diseases such as hypertension and 
diabetes, to debilitating diseases such as Alzheimer’s and autism (Stambrook, 2004). 
  
1.7. Autism and candidate genes 
 
1.7.1. Chromosome 7 as an autism 'hotspot' 
Chromosome 7 spans more than 158 million base pairs in the human genome and represents 
between 5 and 5.5 total DNA in cells. It is likely to contain between 1000 and 1400 genes 
(Schanen 2006, Berg et al., 2007). Many genes located on chromosome 7 have been 
implicated as causative genes for several disorders and diseases (Lord, 2011). These include 
non-syndromic deafness, schizophrenia, William-Beuren Syndrome, colour blindness, 
neurodevelopmental disorders and Tourette syndrome (fig 1.4). Other changes in the structure 
of chromosome 7 can cause delayed growth and development, mental disorders, 
characteristic facial features, skeletal abnormalities, delayed speech and medical problems. 
Several genes on chromosome 7 have been implicated in autism spectrum disorders. Some of 
these genes have been observed to have common transcription binding sites and are involved 
in similar molecular functions and pathways. It is not known why so many of these genes are 
situated on chromosome 7 (table 1.1). 
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Table 1.1: Genes situated on chromosome 7 that have been implicated in Autism 
Gene 
ID 
(NCBI) 
Gene 
Symbol 
Gene Name Location Function Reference 
154664 ABCA13* ATP-binding 
cassette, sub-
family A 
(ABC1), 
member 13 
7p12.3 In human, the ATP-binding cassette (ABC) 
family of transmembrane transporters has at 
least 48 genes and 7 gene subfamilies. This 
gene is a member of ABC gene subfamily A 
(ABCA). It is predicted to have two large 
extracellular domains and two nucleotide 
binding domains as is typical for ABCA 
proteins. Alternative splice variants have 
been described but their biological validity 
has not been demonstrated. 
 
Knight et al., 
2009 
83451 ABHD11* abhydrolase 
domain 
containing 11 
7q11.23 This gene encodes a protein containing an 
alpha/beta hydrolase fold domain. This gene 
is deleted in Williams syndrome, a 
multisystem developmental disorder caused 
by the deletion of contiguous genes at 
7q11.23. Alternatively spliced transcript 
variants have been described, but their 
biological validity has not been determined 
 
Merla et al., 2010 
26047 CNTNAP2 contactin 
associated 
protein-like 2 
7q35 This gene encodes a member of the neurexin 
family which functions in the vertebrate 
nervous system as cell adhesion molecules 
and receptors. May play a role in the 
formation of functional distinct domains 
critical for saltatory conduction of nerve 
impulses in myelinated nerve fibers. Seems 
to demarcate the juxtaparanodal region of the 
axo-glial junction. This gene has been 
implicated in multiple neurodevelopmental 
disorders, including Gilles de la Tourette 
syndrome, schizophrenia, epilepsy, autism, 
ADHD and mental retardation. 
 
Penagarikano et 
al., 2011 
2020 EN2 engrailed 
homeobox 2 
7q36 Homeobox-containing genes are thought to 
have a role in controlling development.  The 
human engrailed homologs 1 and 2 encode 
homeodomain-containing proteins and have 
been implicated in the control of pattern 
formation during development of the central 
nervous system 
Wang et al., 2007 
Choi et al., 2011 
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93986 FOXP2 
 
forkhead box P2 
7q31 This gene encodes a member of the 
forkhead/winged-helix (FOX) family of 
transcription factors. It is expressed in fetal 
and adult brain as well as in several other 
organs such as the lung and gut. The protein 
product contains a FOX DNA-binding 
domain and a large polyglutamine tract and 
is an evolutionarily conserved transcription 
factor, which may bind directly to 
approximately 300 to 400 gene promoters in 
the human genome to regulate the expression 
of a variety of genes. This gene is required 
for proper development of speech and 
language regions of the brain during 
embryogenesis, and may be involved in a 
variety of biological pathways and cascades 
that may ultimately influence language 
development. Mutations in this gene cause 
speech-language disorder 1 (SPCH1), also 
known as autosomal dominant speech and 
language disorder with orofacial dyspraxia. 
Multiple alternative transcripts encoding 
different isoforms have been identified in 
this gene. 
 
Gong et al., 2004 
3198 HOXA1 homeobox A1 7p15.3 In vertebrates, the genes encoding the class 
of transcription factors called homeobox 
genes are found in clusters named A, B, C, 
and D on four separate chromosomes. 
Expression of these proteins is spatially and 
temporally regulated during embryonic 
development. This gene is part of the A 
cluster on chromosome 7 and encodes a 
DNA-binding transcription factor which may 
regulate gene expression, morphogenesis, 
and differentiation. The encoded protein may 
be involved in the placement of hindbrain 
segments in the proper location along the 
anterior-posterior axis during development. 
Two transcript variants encoding two 
different isoforms have been found for this 
gene, with only one of the isoforms 
containing the homeodomain region. 
 
Ingram et al., 
2000 
 
83943 IMMP2L IMP2 inner 
mitochondrial 
membrane 
7q31 Catalyzes the removal of transit peptides 
required for the targeting of proteins from 
the mitochondrial matrix, across the inner 
Petek et al., 2007 
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peptidase-like membrane, into the inter-membrane space. 
Known to process the nuclear encoded 
protein DIABLO. 
 
5649 RELN Reelin 7q22 This gene encodes a large secreted 
extracellular matrix protein thought to 
control cell-cell interactions critical for cell 
positioning and neuronal migration during 
brain development. This protein may be 
involved in schizophrenia, autism, bipolar 
disorder, major depression and in migration 
defects associated with temporal lobe 
epilepsy. Mutations of this gene are 
associated with autosomal recessive 
lissencephaly with cerebellar hypoplasia. 
Two transcript variants encoding distinct 
isoforms have been identified for this gene. 
Other transcript variants have been described 
but their full length nature has not been 
determined. 
Bonora et al., 
2003 
Fatemi et al., 
2005 
Sharma et al., 
2012 
7328 UBE2H ubiquitin-
conjugating 
enzyme E2H 
7q32  
The modification of proteins with ubiquitin 
is an important cellular mechanism for 
targeting abnormal or short-lived proteins for 
degradation. Three alternatively spliced 
transcript variants have been found for this 
gene and they encode distinct isoforms. 
Vourc’h et al., 
2003 
 
7472 WNT2 wingless-type 
MMTV 
integration site 
family member 2 
7q31.2  
This gene is a member of the WNT gene 
family. The WNT gene family consists of 
structurally related genes which encode 
secreted signaling proteins. These proteins 
have been implicated in oncogenesis and in 
several developmental processes, including 
regulation of cell fate and patterning during 
embryogenesis. Alternatively spliced 
transcript variants have been identified for 
this gene. 
Marui et al., 
2010 
Lin et al., 2012 
 
*genes have not been implicated in Autism, but have been implicated as genes of interest as a result of 
microarray studies (and the subsequent bioinformatics analysis) that were done for high- and low-functioning 
affected individuals in a previous study. 
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1.7.2. ABCA13 gene 
 
Figure 1.4: Red line indicates the position of the ABCA13 gene on chromosome 7. 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=ABCA13) 
 
The adenosine phosphate (ATP)-binding casette, sub-family A (ABC1), member 13 gene is 
the largest known protein of the ABC family. Knight, et al. (2009) reported a cytogenic 
abnormality and rare coding variants in ABCA13 that may contribute significantly to the risk 
of schizophrenia, bipolar disorder and major depression. ABCA13 maps to chromosome 
7p12.3, in which multiple rare coding variants were observed (fig 1.4). For this one gene, 1 
nonsense and 9 missense mutations, as well as compound heterozygosity/homozygosity was 
detected in 6 cases in a study sample group (Ovsanna et. al., 2006). 
Although no significant linkage for ABCA13 has been found with Autism Spectrum Disorders, 
there is strong evidence for comorbidity of ASDs with other psychiatric disorders associated 
with the gene. A study was conducted in by Stahlberg et al. (2003) to observe comorbidity of 
ASD and/or ADHD with schizophrenia, bipolar disorder and major depression in adults with 
childhood onset ASD and/ADHD. Of those with ASD, 7% tested for bipolar disorder and 7.8% 
for schizophrenia and other psychiatric disorders. It was also reported that rates of psychiatric 
disorders in ASDs are high and associated with functional impairment (Stahlberg et al., 2003). 
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1.7.3. ABHD11 gene 
 
 
Figure 1.5: Red line indicates the position of the ABHD11 gene on chromosome 7. 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=ABHD11&search=abhd11) 
The anhydrolase domain containing 11 gene (ABDH11), previously known as the William 
Beuren Syndrome (WBS) chromosome region 21 gene is located 7q11.23, a region on 
chromosome 7 that has been implicated in many genetic disorders and diseases. 
WBS is a multisystem developmental disorder caused by the deletion of contiguous genes at 
the 7q11.23 position. Some of these genes include elastin (ELN) and GTF21 implicated as 
causative genes in spatial visual disorders and CAP-GLY Domain Containing Linker Protein 
2 (CLIP2), implicated in behavioural disorders (Chin-See-Chong, et al., 2015). WBS is a rare 
neurodevelopmental disorder that is characterised by an elfin facial appearance, a low nasal 
bridge, an unusually cheerful demeanour and ease with strangers, as well as developmental 
delays, strong language skills and cardiovascular problems (Berg et al., 2007). The estimated 
prevalence for WBS is approximately 1:7 500 to 1 in 20 000. The behavioural phenotype of 
WBS has long been considered to be the polar opposite ASD. New evidence has emerged to 
show that the co morbidity for autism with WBS is more frequent than previously thought. 
The research suggests that common WBS deletions can result in a continuum of social 
communication impairments like excessive talkativeness and over friendliness, as well as the 
absence of verbal language and poor social relationships (Tordjman et al., 2012). Using 
clinical and molecular examination methods, it was reported that nine French individuals 
were found to have co-morbidity for ASD and WBS (Tordjman et al., 2012). Of the 
individuals studied, female children were more prone to excessive talkativeness, whereas the 
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male children in the group were non-verbal. All the children were found to have the WBS 
deletion, and were placed on the autism spectrum. 
 
Figure 1.6: Diagram depicting gene-linked diseases and disorders on chromosome 7 
(http://www.dnarss.com/Chromosome_7.html) 
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Hypothesis: 
I hypothesised that three SNPs from two genes on chromosome 7 is associated with 
autism in a South African population. 
Aim: 
The main aim of this body of work was to genotype SNPs in a South African healthy and 
affected population 
Objectives: 
• Genotype rs10279013 from ABHD11 and compare the allelic distribution in a healthy 
and affected South African population 
• Genotype rs2293484 from ABHD11 and compare the allelic distribution in a healthy 
and affected South African population 
• Genotype rs17060 from ABCA13 and compare the allelic distribution in a healthy and 
affected South African population 
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CHAPTER 2: MATERIALS & METHODS 
2.1. Methods of genotyping 
The process of determining differences in the genetic make-up (genotype) of an individual by 
examining the individual's DNA sequence using biological assays and comparing it to 
another individual's sequence or a reference sequence is known as genotyping. It reveals 
the alleles an individual has inherited from their parents. Traditionally genotyping is the use 
of DNA sequences to define biological populations by use of molecular tools. It does not 
usually involve defining the genes of an individual. 
Traditional genotyping methods include restriction fragment length polymorphism (RFLP) 
and single-stranded conformational polymorphism (SSCP) (Itoga et al., 2004). Chip-based 
genotyping assays, combined with knowledge of the patterns of coinheritance of markers 
(linkage disequilibrium [LD]), have stimulated genome-wide association studies (GWAS) of 
complex diseases. Recent successes of GWAS in identifying specific genes that affect risk for 
common diseases are dramatic illustrations of how improved technology can lead to scientific 
breakthroughs. A key issue in high-throughput genotyping is to choose the appropriate 
technology for goals and for the stage of the experiment, being cognizant of sample numbers 
and resources (Edenberg and Liu, 2009). 
2.2. Ethical Clearance 
The project was approved by the Western Cape Ethics Committee (SR: 5/9/33) of the 
University of the Western Cape and the Western Cape Education Department. Consent was 
also obtained from principals of schools and parents for collection of samples for DNA 
analysis (Appendices 1 – 3) in accordance with the Helsinki Declaration. 
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Subjects for the study were chosen from three different ethnic groups in the South African 
population; namely Caucasian (White), African (Black) and Mixed population (Coloured). 
The present study group was comprised of 81 autistic black, 82 autistic white and 56 autistic 
mixed individuals. The number of control individuals was 83, 82 and 56, respectively. 
Subjects were between the ages of 4-16, from schools in Cape Town, Kwa-Zulu Natal and 
Pretoria, both male and female. Samples were collected from children who were diagnosed 
with Autism Spectrum Disorder(s), as per a psychologist and paediatrician, as well as from 
healthy children of the same ethnic groups and age group. 
2.3. Sample collection 
DNA samples were collected by rubbing a sterile swab (Puritan Sterile Polyester Tip 
Applicators, Manta Forensics, South Africa) on the inside of the cheek for 1 minute and 
placing it into a labeled sterile 15ml falcon tube (Boeco, Germany). The same procedure was 
repeated for the other cheek. Tubes were labeled carefully with a sample number, the child’s 
name, date of birth and ethnicity. In addition to this, clinical information was provided by the 
psychologist or parent/guardian with regards to any complications during the mothers’ 
pregnancy as well as ongoing neurological and physical health issues. 
2.4. Isolation of DNA 
DNA was extracted from the swabs using the BuccalAmpTM Extraction Kit (Epicentre, 
USA). The swab tip was placed into a labelled 2 ml eppendorf tube, with the excess of the 
swab snapped off. 250 ml of the QuickExtract DNA solution 1.0 was added to the tube and 
incubated at 65°C for 1 minute. They were then mixed by vortexing for 15 seconds and 
incubated at 98°C for 4 minutes. Thereafter they were again vortexed for 15 seconds. Tubes 
were stored at -20°C. 
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2.5. Quantitation of DNA 
The concentration of each DNA sample was determined using the NanoDrop® ND-1000 
spectrophotometer (NanoDrop Technologies, USA). 
 
2.6. Taqman Genotyping 
 
2.6.1. Methods of SNP detection 
With all the information available about the molecular mechanism of SNPs, researchers have 
developed a variety of detection methods for analysing the presence of SNPs in the human 
genome. The majority of these techniques are based on basic PCR protocols, with added 
technology to enhance the efficacy of looking for and analysing. New technology looks at 
developing genotyping methods that high throughput, accurate and inexpensive (Syvanen, 
2001). 
2.6.2. Taqman® SNP Genotyping Assay 
The Taqman® SNP Genotyping Assay is a rapid fluorophore-based real-time PCR method. It 
measures the accumulation of amplified product during the exponential phase of the PCR 
cycle. Two fluorescent probes, VIC and FAM, detect the presence of alleles 1 and 2, 
respectively. When both probes are fluoresced, this indicates heterozygosity for both alleles 
(figure 2.1.). 
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Figure 2.1: The active mechanism of the Taqman SNP Genotyping method 
(http://www.dnavision.com/taqman-genotyping-assays.php) 
 
SNP genotyping using the Taqman® method has been shown to be wholly successful in the 
detection of SNPs. It has been used to characterize the APOE haplotypes in Alzheimer’s 
disease (Livak, 1999) and has been used to identify an association between two SNPs and 
autism in the Chinese Han population (Wang et al., 2008). 
2.7. Gene and SNP selection 
 
Two genes from chromosome 7 that have not been previously implicated in Autism but have 
been linked to other disorders co-morbid to Autism were selected; namely ABHD11 and 
ABCA13 and from these genes, two SNPs were selected per gene for further investigation. 
These SNPs were rs2293484 (intronic) and rs10279013 (intronic) from ABHD11 and rs17060 
(intronic) from ABCA13. These genes were also implicated as genes of interest by microarray 
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analysis in a previous study (Gameeldien et al., 2009). The SNP sequences were blasted 
against the Homo sapiens genome using the BLAST tool at NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Primers were then manufactured by Applied 
Biosystems according to the specifications as indicated by the File Builder application. The 
Taqman® Custom Genotyping Assay probes (40x) were labelled VIC and FAM to the 
respective sequences for each SNP: 
rs2293484: VIC: 5’ – AGGGTCCCCAGGCTGGGGCCTGGGC – 3’ 
                   FAM: 5’ – AGTAAAGCATGCCCCTCCTACTACC – 3’ 
 
rs10279013: VIC: 5’ – GAGGAGGCCCCAGACATGGGCGGCT – 3’ 
                     FAM: 5’ – ACCCTCTGTAGTGCCAGCAGCATGG – 3’ 
 
rs17060:    VIC: 5’ – ATATGGACTCATTTCTTCTTTGCATC – 3’ 
        FAM: 5’ – TTATTTCTAGGTTATTTGCAGCCCCG – 3’ 
 
2.8. PCR preparation 
DNA samples were prepared by diluting samples to a final concentration of 20ng/µl with 
double SABAX water in 96-deepwell plates (Applied Biosystems, USA), based on the 
concentrations obtained. 50µl of SABAX water was aliquoted into the first row (row A) of 
each of the 96-deepwell plates to serve as the negative control. A PCR mastermix for 650 
samples was prepared as follows: 
1650 µl of Taqman® Universal Genotyping Mastermix (Applied Biosystems, USA) was 
added to a tube. 165µl of 20x Taqman® SNP Custom Genotyping Assay (Applied 
Biosystems, USA) was added to the tube, along with 825 µl of SABAX water. The solution 
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was vortexed for 10 seconds to mix. Samples and the mastermix were then transferred into a 
384-well PCR plate (Applied Biosystems, USA) to a final volume of 5 µl, using the 
Eppendorf epMotion 5070 automated pipetting system (Applied Biosystems, USA). 
The dilution of samples for this experiment was the most important step. The Taqman® 
Genotyping Assay is highly sensitive and is able to detect minute amounts of contamination, 
which affects the end result of the experiment negatively. Samples were thus prepared under 
highly sterile conditions. The use of the Epimotion Automated Pipetting system was proven 
to be time efficient and reduced the risk of human error. Non-template samples were used in 
regular intervals throughout the experiment to indicate if contamination had occurred. Due to 
the time lapse in between running some of the SNP assays, fresh dilutions were prepared to 
ensure accurate results. 
2.9. PCR amplification 
The Perkin Elmer 9700 PCR System (Applied Biosystems, USA) was used for PCR 
amplification. PCR parameters were carried out according to the standard PCR protocol 
provided by the manufacturer. An initial holding step was applied for 10 minutes at 95°C, 
followed by 40 cycles of the following: 
• Initial denaturation for 10 min at 95°C 
• Denaturation for 15 sec at 92°C                              40 cycles 
• Annealing for 1 min at 60°C 40 cycles                
• Extension for 1 min at 60°C 
 
2.10. Statistical sample analysis 
Allele frequencies for the A and G variants were calculated using the Hardy-Weinberg 
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equation. Chi square testing was performed to compare the number of alleles of the South 
African autistic group to the South African control group at a confidence interval of 95%, to 
compare and determine the significance between different populations (Esau et al., 2008). 
Chi square testing was done using the standard 2-by-2 and 3-by-2 method and validation of 
these results was done using http://www.vasserstats.net and http://www.danielspoer.com. 
Genotype percentages and chi square testing was applied as per the autistic sample group. It 
is to be noted that these methods of analyses were applied for the genotyping of all 
subsequent SNPs. 
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CHAPTER 3: RESULTS 
 
3.1. Genotyping results for autistic and healthy populations 
Genotyping results were obtained following PCR amplification and subsequent viewing with 
the Applied Biosystems 7900HT Real-Time PCR system. The raw genotyping data was 
displayed in a graphical output file (fig. 3.1). The data represents autistic and control samples, 
as well as negative controls (NTCs). Cluster A represents the wild-type homozygous 
genotype; cluster C represents the mutant homozygous genotype, while cluster B shows the 
heterozygous alleles. Cluster D represents the negative controls. 
 
Figure 3.1: Graphical data output for Taqman ® SNP Genotyping Assay 
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3.2. SNP genotyping analysis 
 
3.2.1. Genotyping analysis for rs10279013 
For the autistic sample group, 219 samples were genotyped, with the majority of these 
displaying the homozygous C allele (table 3.1). For the control sample group, 218 samples 
were genotyped, with the majority of individuals again displaying the CC genotype as 
dominant. There was no representation of the homozygous T allele for this sample group. The 
CC genotype in the autistic and the healthy groups in the total SA population was 93% and 
73%, respectively. The CT genotype in the autistic and the healthy groups in the total SA 
population was 7% and 27%, respectively (figures 3.2 and 3.3).  The comparison of the 
genotypes for the autistic and healthy groups showed statistical significance, with P=0.00093. 
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Table 3.1. Genotype and allelic distributions of rs10279013 on ABHD11 in 3 distinct ethnic 
groups in the South African autistic and healthy population 
*values in red are highly significant, where p-value <0.0001. 
 
 
 
Ethnic 
Group 
Number Genotype (%) P-value Allele (%) P-value 
  
CC TT CT  C Allele T Allele  
Total South African     
Autistic  219 203 (93) 0 16 (7) 0.00093 422 (96) 16 (4) 0.00014 
Control 218 158 (73) 0 60 (27)  376 (86) 60 (14)  
SA Black     
Autistic  81 70 (86) 0 11 (14) 0.70828 151 (93) 11 (7) 0.71843 
Control 83 70 (84) 0 13 (16)  153 (92) 13 (8)  
SA Caucasian     
Autistic  82 80 (98) 0 2 (2) 0.000191 162 (99) 2 (1) 0.00016 
Control 60 46 (77) 0 14 (23)  106 (88) 14 (12)  
SA Mixed     
Autistic  56 53 (95) 0 3 (5) 0.00016 109 (97) 3 (3) 0.00012 
Control 75 42 (56) 0 33 (44)  117 (78) 33 (22)  
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Figure 3.2: Percentage of genotype distributions for rs10279013 on the ABHD11 gene in an autistic South 
African population 
 
 
Figure 3.3: Percentage of genotype distributions for rs10279013 on the ABHD11 gene in a healthy South 
African population 
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The SA Black group displayed high numbers of individuals with the homozygous CC 
genotype, with the autistic group at 86% and the control group at 84%. The heterozygous CT 
genotype had a low prevalence of 14% in the autistic group and 16% in the controls. The 
homozygous TT genotype was not found in any individuals in this group. There was no 
statistical significance for this allele, at P=0.70828. 
In the SA Caucasian group, 98% autistic individuals displayed the CC genotype, with 77% in 
the control group. The control group showed 23% and 2% in the autistic group for the 
heterozygous CT genotype. Again, the homozygous TT genotype was not represented in this 
sample group. The difference in genotypic frequency between the autistic and healthy groups 
was statistically significant, with P=0.000191. 
The SA Mixed group showed a high number of individuals in the autistic group displaying 
the CC genotype, at 95%. In the control group, that number is just over half of the autistic, at 
56%. The CT heterozygous genotype is at a very low 5% in the autistic group, with a much 
higher number of 44% in the controls. Once again, the TT homozygous allele was not 
represented. With P=0.00016 and 0.00012 respectively, statistical significance is indicated by 
the difference between the genotype frequencies for the autistic and healthy group. 
3.2.2. Allele frequency analysis for rs10279013 
For the C allele, the autistic group displayed 96% of the total South African group having this 
allele and the control number was at 86%. In contrast, numbers were very low for the T 
allele, with 4% and 14% in the autistic and control samples, respectively (table 3.1 and 
figures 3.4 and 3.5). However, the differences between the autistic groups compared to the 
healthy groups was highly significant, where P=0.00014. 
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Figure 3.4: Percentage of allelic distributions for rs10279013 on the ABDH11 gene in an autistic South 
African population. 
 
Figure 3.5: Percentage of allelic distributions for rs10279013 on the ABHD11 gene in a healthy South 
African population 
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Overall, the autistic group showed high numbers of individuals displaying the C allele, with 
all ethnic groups above 90%. In the SA African group, 93% displayed the C allele in the 
autistic group, with 92% in the controls. For the T allele, numbers were very low, with 7% 
and 8% in the autistic and control groups, respectively. Allelic composition of the healthy and 
autistic groups showed a slight difference, but this difference was not statistically significant, 
with P=0.71843. 
The SA Caucasian group displayed high numbers of individuals displaying the C allele, with 
99% and 88% in the autistic and controls, respectively. The T allele was represented by low 
numbers in both groups with only 1% in the autistic sample group, and 12% in the controls. 
These percentages indicate a high statistical significance between the allele frequencies for 
the autistic and healthy groups, with P=0.00016. 
In the SA mixed group, 97% of the autistic samples were found to represent the C allele and 
78% for this allele was displayed by the control group. For the T allele, 3% was displayed by 
the autistic group, with the control group at a higher 22%. There is a highly significant 
statistical difference between the allelic numbers for the autistic and healthy group, with 
P=0.00012. 
3.2.3. Genotyping analysis for rs2293484 
In the total SA population (autistic and healthy), over 50% of the individuals genotyped were 
homozygous for the GG genotype. The CC genotype was distributed in low numbers in both 
autistic and healthy groups, at 10% and 7% respectively. The GG genotype was 53% and 
55% for the autistic and healthy groups and the CG genotype was 37% and 38% respectively 
for the autistic and healthy populations. No significance was found when comparing the 
genotype frequencies for the autistic and healthy groups, with P=0.47237 (table 3.2).  
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Table 3.2: Genotype and allelic distributions of rs2293484 on ABHD11 in 3 distinct ethnic 
groups in the South African autistic and healthy populations 
*values in red are highly significant, where p-value <0.0001. 
 
 
 
 
 
 
Ethnic 
Group 
Number Genotype (%) P-value Allele (%) P-value 
  CC CG GG  C Allele G Allele  
Total South African     
Autistic  197 20 (10) 72 (37) 105 (53) 0.47237 183 (39) 281 (61) 0.00018 
Control 220 15 (7) 83 (38) 122 (55)  122 (28) 318 (72)  
SA Black     
Autistic  67 7 (11) 25 (37) 35 (52) 0.20413 39 (29) 95 (71) 0.76418 
Control 62 2 (3) 30 (48.5) 30 (48.5)  34 (27) 90 (73)  
SA Caucasian     
Autistic  74 7 (9) 26 (35) 41 (56) 0.96856 41 (28) 107 (72) 0.64677 
Control 71 6 (8) 24 (34) 41 (58)  36 (25) 106 (75)  
SA Mixed     
Autistic  56 7 (8) 38 (44) 42 (48) 0.66739 32 (29) 79 (71) 0.84148 
Control 87 6 (11) 21 (37) 29 (52)  52 (30) 122 (70)  
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Figure 3.6: Percentage of genotype distributions for rs2293484 on the ABHD11 gene in an autistic South 
African population 
 
Figure 3.7: Percentage of genotype distributions for rs2293484 on the ABHD11 gene in a healthy South 
African population. 
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For the SA Black population, the frequencies of the CC genotype was 11% and 3%, among 
the autistic and healthy groups, respectively. The GG genotype was dominantly expressed in 
both groups, but was somewhat higher in the autistic group at 52% as opposed to the 48% in 
the healthy group. The heterozygous CG genotype was 37% and 48.5% in the autistic and 
healthy groups, respectively. No statistical significance was found with P=0.20413 (fig. 3.6 
and 3.7). 
The SA Caucasian population had similar genotype distributions to the SA Black group. The 
homozygous GG genotype was expressed in the majority of individuals, with 56% and 58% 
in the autistic and healthy groups, respectively. The homozygous CC genotype was displayed 
at low vales, 9% and 8% in autistic and healthy groups, respectively. The heterozygous CG 
was expressed in 35% and 34% in the autistic and healthy populations, respectively. No 
statistical significance was found with P=0.096856. 
In the SA Mixed population, the GG genotype was once again dominantly expressed in both 
autistic and healthy groups with a value of 48% and 52% respectively. The homozygous CC 
had the lowest values for both groups at 11% and 8% in the autistic and healthy populations, 
respectively. The CG heterozygous genotype was expressed at 44% in the autistic group and 
slightly lower in the control group at 33%. However, when comparing the autistic and the 
control samples, no statistical significance was found.  
 
3.2.4. Allelic frequency distributions for rs2293484 
Sixty-one percent of the individuals genotyped in the total South African autistic group 
expressed the G allele. In the control group, that number was at 72%. The C allele was 
displayed at lower levels, with 39% and 28% in the autistic and healthy groups respectively. 
Statistical significance was found when comparing the allelic frequencies of the autistic and 
 
 
 
 
 47 
healthy groups, with P=0.00018. 
 
Figure 3.8: Percentage of G and C alleles displayed for rs2293484 on the ABHD11 gene in an autistic 
South African population 
 
Figure 3.9: Percentage of G and C alleles displayed for rs2293484 on the ABHD11 gene in a healthy South 
African population 
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In the SA Black population, the G allele was distributed at 71% in the autistic population and 
73% in the control group. The C allele was expressed at less than that amount, 29% and 27% 
in the autistic and healthy groups, respectively. No statistical significance was found, with 
P=0.76418 (fig 3.8 and 3.9). 
The healthy SA Caucasian group had the highest expression levels for the G allele, across the 
population for all ethnic groups, at 75%. The autistic group displayed this allele in 72% of 
individuals. The C allele was expressed at 25% and 28% in the control and autistic groups, 
respectively. No statistical significance was found when comparing the allelic frequencies for 
the autistic and healthy populations, with a P-value of 0.64677. 
The SA Mixed population showed similar frequencies for the C and G alleles as the other 
ethnicity groups, with the G allele again being highly expressed in both the autistic and 
healthy groups, both in the region of and the C allele in the region of 30%70%. No statistical 
significance was found when comparing the association of the G and C allelic frequencies in 
the autistic and healthy populations, with P=0.84148. 
3.2.5. Genotyping analysis for rs17060 
In the total SA population, the homozygous CC genotype was dominant at 53% in the autistic 
group and 60% in the control group. The heterozygous CT genotype was similar for both 
groups, with 39% in the autistic group and 35% in the controls. The TT homozygous 
genotype was very low for both groups at 8% and 5% respectively (table 3.3). There was no 
statistical significance found when comparing the total autistic and healthy groups, with 
P=0.41066. 
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Table 3.3: Genotype and allelic distributions for rs17060 from the ABCA13 gene in South 
African healthy and autistic groups 
*values in red are highly significant, where p-value <0.0001. 
 
 
 
 
 
Ethnic 
Group 
Number Genotype (%) P-value Allele (%) P-value 
  CC CT TT  C Allele T Allele  
Total South African     
Autistic  206 112 (53) 80 (39) 14 (8) 0.41066 331 (78) 95 (22) 0.20032 
Control 213 128 (60) 75 (35) 10 (5)  331 (78) 95 (22)  
SA Black     
Autistic  75 31 (41) 35 (47) 9 (12) 0.72885 97 (65) 53 (35) 0.43479 
Control 74 35 (47) 32 (43) 7 (10)  102 (69) 46 (31)  
SA Caucasian     
Autistic  80 50 (63) 26 (32) 4 (5) 0.05558 125 (79) 34 (21) 0.01991 
Control 70 54 (77) 16 (33) 0  125 (89) 16 (11)  
SA Mixed     
Autistic  51 31 (61) 19 (37) 1 (2) 0.79399 81 (79) 21 (21) 0.54300 
Control 69 39 (56) 27 (39) 3 (5)  105 (76) 33 (24)  
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Figure 3.10: Percentage of genotype distributions for rs17060 on the ABCA13 gene in an autistic South 
African population. 
 
Figure 3.11: Percentage of genotype distributions for rs17060 on the ABCA13 gene in a healthy South 
African population. 
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The SA Black population showed that 41% of individuals in the autistic group were 
homozygous for the CC genotype, while the respective figure in the control group was 47%. 
The heterozygous CT genotype was present at 47% and 43% in the autistic and control 
groups, respectively. The respective values for the TT genotype was 12% and 10% in both 
autistic and control groups. When comparing the different genotypes, no significant 
difference was found between the autistic and control groups, with P=0.72885. 
In the SA Caucasian group, the frequency of the CC genotypes among the autistic and control 
groups was 63% and 77% respectively. The heterozygous CT genotype was present in 32% of 
individuals in the autistic group and 33% in individuals in the control group. The TT 
homozygous genotype was under-represented in both groups, with 5% in the autistic group 
and none of the individuals in the control group tested for the TT genotype (fig 3.10 and 3.11). 
When comparing the different genotypes, no significant difference was found between the 
autistic and control groups, with P=0.0.5558. 
For the SA mixed group, genotype frequency of the CC, CT and TT genotype among the 
healthy group was 56%, 39% and 5%, whereas in the autistic group the same was found to be 
61%, 37% and 2%, respectively. When comparing the different genotypes, no significant 
difference was found between the autistic and control groups, with P=0.79399. 
 
 
 
 
 52 
 
Figure 3.12: Percentage of A and C alleles displayed for rs17060 on the ABCA13 gene in an autistic South 
African population 
 
Figure 3.13: Percentage of A and C alleles displayed for rs17060 on the ABCA13 gene in a healthy South 
African population 
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3.2.6. Allelic analysis for rs17060 
 
In the total SA population, the frequency of the dominant C allele, was 78% for in both 
healthy and autistic groups. The T allele frequency was 22% in both the healthy and autistic 
groups (fig. 3.12 and fig. 3.13). No statistical significance was found when comparing the 
autistic and healthy populations, with P=0.20032. 
In the SA Black population, the frequency of the C allele was the highest, with 65% in the 
autistic group and 69% in the controls, respectively. The T allele was displayed at 35% and 
31% for autistic and control groups, respectively. No significance was found when comparing 
the autistic and control groups, with P=0.43479. 
The SA Caucasian group had the highest values for the C allele across all the ethnic groups, 
with 79% in the autistic group and 89% in the control group. The T allele was lower at 21% 
and 11% respectively. The difference of allelic frequency of autistic and healthy groups was 
found to be statistically significant, with P=0.01991. 
In the SA Mixed group, the frequency for the C allele was 79% in the autistic group and 76% 
in the control group. The T allele was displayed at 21% and 24% respectively, with no 
statistical significance found when the allelic frequency for the autistic and healthy groups 
was compared, where the P-value=0.54300. 
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Chapter 4:  A BIOINFORMATICS APPROACH TO IDENTIFYING CANDIDATE 
GENES INVOLVED IN AUTISM 
4.1. Introduction 
Over the past two decades, more than 1200 genes causing human diseases or traits have been 
identified, largely by a process that is called ‘positional cloning’ (Bostein and Risch, 2003). 
Through positional cloning, genes controlling Mendelian traits or diseases are identified and 
isolated with only the prior information that the phenotype is inherited. One of the most 
successful and widely-used methods of candidate gene discovery is by the use of single 
nucleotide polymorphisms (SNPs). Linkage analysis is dependent on the availability of 300-
500 highly informative genetic markers spanning the entire genome and this research is 
applied on families (Collins et al., 1998). However it is considerably harder to look for genes 
contributing to the risk of heart disease, cancers and psychiatric disorders as these phenotypes 
are affected by multiple genes, each with a small effect in combination with environmental 
factors. While these classic methods of candidate gene discovery have been wholly useful in 
laying the foundation for effective genetic research, these methods are limited by its reliance 
on previous knowledge of the physiological, biochemical and functional aspects of possible 
candidates (Zhu and Zhao, 2007). 
Bioinformatic resources prove invaluable in facilitating gene identification. Genomic 
information is cumulative and the availability of the collected knowledge of human genetics 
has proven to be the central success of the Human Genome Project. Processes that used to be 
very tedious and labour intensive such as physical mapping has become a simple process of 
PCR with data being sent to a website and results sent to the requestor via email (Bostein and 
Risch, 2003). 
Computational analysis and bioinformatics in genetic studies has proven to be an invaluable 
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research tool. Data-intensive research has been made simpler in terms of analysis and 
database maintenance (Perez-Iratxeta et al., 2007). One of the important and extremely useful 
roles these types of databases play in biological studies is that they are able to organize genes 
and proteins within their larger biological context. This includes identifying common 
pathways and protein interactions of various genes and proteins in different biological 
functions (Romero et al., 2004). 
4.2. STRING database (http://www.bork.embl-heidelberg.de/STRING/) 
Direct physical binding is not the limitation of protein-protein interactions. They may also 
interact indirectly – by sharing a substrate in a metabolic pathway, regulating each other 
transcriptionally, or during participation in larger multi-protein assemblies (von Meiring et 
al., 2003). The prediction of these functional associations (for direct and indirect binding) is 
made simpler by the current rate and growth of genomic information becoming available. 
This information offers unique opportunities of inference methods through ‘genomic context’ 
or ‘nonhomology-based’ information (Galperin and Koonin, 2000; Marcotte, 2000; Huynen 
et al., 2000). 
The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) is a wide-ranging 
visual database that assimilates information on known and predicted protein interactions 
(Snel et al., 2000). This database offers a unique visual representation of very specific 
protein-protein interaction networks, which can be manipulated by adding more proteins, 
taking them away or changing their positioning within the network (Jensen et al., 2009; 
Sklarczyk et al., 2011). STRING can also be used to identify new/unknown proteins in a 
specific network of genes. The latest version of STRING covers more than 1100 completely 
sequenced organisms. Interactions include direct and indirect associations and these are 
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derived from four sources: genomic context, high-throughput experiments, conserved co-
expression and previous knowledge (http://string-db.org). 
 
 
Fig. 4.1: An example of the visual representation of a STRING network (http://string-
db.org/version_9_05/newstring_cgi/show_network_section.pl?limit=0&targetmode=proteins&caller_iden
tity=gene_cards&network_flavor=evidence&identifiers) 
4.3. GeneCards® (http://www.genecards.org) 
The Weizmann Institute of Science in collaboration with Life Map Sciences Incorporated 
established the GeneCards ® database in 1997 with the aim to integrate the massive amounts 
of genomic data being generated by the Human Genome Project and subsequently spread 
over various specialized databases (Reghan et al., 1997). The current version automatically 
mines over 90 sources in an offline process and constructs a combined gene list as follows: 
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Fig 4.2: The methodology used by the GeneCards ® database to mine and store information on all known 
genes 
These primary sources of information provide annotations for aliases, descriptions, previous 
symbols, gene category, location, summaries, paralogues and non-coding RNA details 
(Stelzer et al., 2011). The GeneCards database provides the user with a comprehensive, 
multifaceted tool that allows for the characterization of genes from the most basic point, the 
nucleotide, right up to the associated pathways, protein interactions and modifications, 
protein domain information, transcriptional information and gene expression while providing 
researchers a summarized look at complicated genomic data for use in molecular research 
(Safran et al., 2010). 
4.4. Transcription factors and binding sites 
The most common identifier for transcription factors (TFs) is that they are proteins that bind 
to specific DNA sequences, thereby controlling the flow of genetic information from DNA to 
mRNA. TFs either perform this function alone or with other proteins in a complex, by 
activating or blocking the recruitment of RNA polymerase to specific genes. 
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A defining factor for TFs is that they contain one or more DNA-binding domains which 
attach specific sequences of DNA adjacent to the genes they regulate. The efficiency of TFs is 
responsible for the regulation and control of all biological functions in eukaryotic organisms. 
Muscle differentiation in embryonic development (MYOD), helping kidneys reclaim water at 
times of dehydration (NR3C2) and even the instigation of oncogenesis (MYC) are just some 
of the examples of the functions that TFs serve (Yusuf et al., 2012). 
Many TFs are implicated in disease. Out of a growing list of 1321 human TFs, 197 are 
currently linked to one or more diseases in the OMIM Morbid Map (Yusuf et al., 2012; 
Fulton et al., 2009 and Vaquerizas et al., 2009). The Transcription Factor Encyclopedia is a 
web-based compendium of literature and content regarding information on transcription 
factors. Much in the style of GeneCards®, the TF Encyclopedia offers a comprehensive look 
at identified TFs from human, rat and mouse. However, the information output is available in 
pdf format, in the form of mini reviews written and vetted by experts in the field 
(http://www.dimasyusuf.com/transcription-factor-encyclopedia-website/). 
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 Aims and objectives of this chapter 
Aim: The main aim of this chapter is to ascertain whether the genes on chromosome 7 have 
any common pathways and/or regulating transcription factors that may attribute to the fact 
that chromosome 7 is viewed as an “autism hotspot’. 
Objectives: Further objectives of the study are: 
• The identification of additional potential candidate genes, using the STRING 
database 
• The bioinformatics analysis of the candidate genes by summarizing genomic 
information provided by the freely-available GeneCards® database 
• The identification of common transcription factors regulating the identified 
candidate genes 
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4.5. Materials and methods 
4.5.1. Identification of potential candidate genes 
A list of already identified candidate genes from chromosome 7 was identified from literature 
(table 1). A search was then performed in the STRING database, using the genes as the input 
query to determine further candidate genes on chromosome 7 interacting with the existing list 
of genes from the literature. The default parameters were used. The top results from the 
STRING search - only genes with a confidence score of 0.9 and above were included in the 
network, and no more than 20 genes were included in the network - as well as the existing list 
of candidate genes was included. The full list of genes then further investigated by submitting 
them to a GeneCards® database search. This was done to obtain specific information 
regarding the molecular function(s) of the genes, interacting transcription factors and any 
involvement in autism or ASDs. Characteristics of interest included cellular location of the 
gene, molecular function, participation in a molecular process, possible involvement in 
cellular processes, protein-protein interactions, domains present in the gene and the presence 
of transcription factor binding sites in the promoter region of the gene. 
 
4.6. Results 
9 candidate genes, already positively linked to autism and ASDs by previous studies (table 1) 
were subjected to STRING analysis. A further 19 genes were identified as co-expressed genes 
with the list of previously identified candidate genes from chromosome 7. Of the 19 
identified genes, two were found to be located on chromosome 7. 
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4.6.1. GeneCards®  results 
A summary of the GeneCards® results assigning basic functional annotations for the 9 
previously identified genes, as well as the two genes from the STRING analysis can be seen 
in table 4.2. 
While there was no direct link to Autism and ASDs in the criteria that was investigated, the 
GeneCards® results for most of the candidate genes yielded information pertaining to 
transcriptional activities as important molecular processes that the genes are involved in. 
GeneCards® also substantiated the results as per table 1, showing the associated disorders 
and diseases for the different candidate genes. For the genes identified by the previous 
microarray study carried out by this research group (Gameeldien 2010), ABCA13 and the 
FZD9 and FZD1 genes identified by the STRING interactions, all 3 showed  associated 
diseases or disorders that have been  proven to be co-morbid with Autism and ASDs
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Table 4.1: Summary of Genecards ® results 
Gene name and symbol 
WNT2 
wingless-type MMTV integration site family member 2 
Alternative names 
Int-1-Like Protein, Secreted Growth Factor 
Cellular location of protein 
extracellular region, proteinaceous extracellular matrix, extracellular space, colocalizes with plasma membrane 
 
Molecular function 
receptor binding, frizzled binding, frizzled-2 binding, cytokine activity, receport agonist activity 
 
Molecular process 
positive regulation of endothelial cell proliferation, positive regulation of mesenchymal cell proliferation, lens 
development in camera-type eye, signal transduction, cell-cell signalling 
 
Cellular pathways 
DNA damage response, Wnt signaling pathway, Wnt signaling network 
 
Protein domains 
Belongs to the Wnt family 
Protein-protein interactions 
FZD1, FZD9, SFRP1, WNT3A, WNT2B 
 
 
 
 
Gene name and 
symbol EN2 
 
Engrailed Homeobox 2 
 
Alternative names Homeobox Protein Engrailed-2, Engrailed Homolog 2, Engrailed-2 
 
Cellular location of 
protein 
nucleus, membrane 
 
Molecular function 
sequence-specific DNA binding transcription factor activity, sequence-specific DNA 
binding 
 
Molecular process 
multicellular organismal development, neuron differentiation, midbrain development, 
hindbrain development, positive regulation of transcription from RNA polymerase II 
promoter 
 
Cellular pathways - 
 
Protein domains 
Belongs to the engrailed homeobox family, Contains 1 homeobox DNA-binding 
domain 
 
Protein-protein 
interactions 
FOXA2 
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Table 4.1 continued 
Gene name and 
symbol IMMP2L 
 
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) 
 
Alternative names 
Mitochondrial Inner Membrane Protease Subunit 2, Inner Mitochondrial Membrane 
Peptidase 2 Like 
 
Cellular location of 
protein 
nucleus, mitochondrion, integral to membrane, mitochondrial inner membrane 
peptidase complex 
 
Molecular function peptidase activity, serine-type peptidase activity 
 
Molecular process 
ovarian follicle development, proteolysis, protein processing involved in protein 
targeting to mitochondrion, spermatogenesis, ovulation 
 
Cellular pathways Protein export 
 
Protein domains Belongs to the peptidase S26 family. IMP2 subfamily 
 
Protein-protein 
interactions ALDH1B1, GPX4, GUF1, HACL1, IDO2 
 
 
 
 
Gene name and 
symbol FOXP2 
 
Forkhead Box P2 
 
Alternative names CAG Repeat Protein , Forkhead/Winged-Helix Transcription Factor, Forkhead Box Protein P2, Trinucleotide Repeat Containing 10 
Cellular location of 
protein 
nucleus, transcription factor complex, cytoplasm 
 
Molecular function 
DNA binding, chromatin binding, double-stranded DNA binding, sequence-specific 
DNA binding transcription factor activity, RNA polymerase II distal enhancer 
sequence-specific DNA binding transcription factor activity 
 
Molecular process 
positive regulation of mesenchymal cell proliferation, pattern specification 
process, skeletal muscle tissue development, embryo development, post-embryonic 
development 
 
 
Cellular pathways Wnt / Hedgehog / Notch 
Protein domains 
The leucine-zipper is required for dimerization and transcriptional repression 
 
(By similarity), Contains 1 C2H2-type zinc finger, Contains 1 fork-head DNA-binding 
domain 
 
Protein-protein 
interactions 
FOXP1, FOXP4, GATAD2B, CTBP1, NFATC2 
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Table 4.1 continued 
Gene name and 
symbol RELN 
 
Reelin 
 
Alternative names RL, PRO1598 
 
Cellular location of 
protein proteinaceous extracellualr matrix, extracellular space, cytoplasm, dendrite 
Molecular function 
 
protein serine/threonine/tyrosine kinase activity, serine-type peptidase 
activity, metal ion binding, lipoprotein particle receptor binding, very-low-density 
lipoprotein particle receptor binding 
 
Molecular process 
 
 
cell morphegenisi involved in diferentiation, neuron migration, proteolysis, cell 
adhesion, axon guidance 
 
Cellular pathways 
 
Focal adhesion, ECM-receptor interaction 
 
Protein domains Belongs to the reelin family, 16BNR repeats, 8 EGF-like domains, 1 reelin domain 
 
Protein-protein 
interactions 
LRP8, VLDLR, DAB1, PCDHA4, PCDHA6 
 
 
 
 
 
 
Gene name and 
symbol ABCA13 
 
ATP-binding cassette, sub-family A (ABC1), member 13 
 
Alternative names 
 
ATP-Binding Cassette, Sub Family (ABC1), ATP Binding Cassette Transporter 
 
Cellular location of 
protein 
integral to membrane 
 
Molecular function ATP binding, ATPase activity 
Molecular process 
 
Transport 
 
Cellular pathways 
 
ABC transporters 
 
Protein domains Belongs to the ABC transporter superfamily, 2 ABC domains 
 
Protein-protein 
interactions 
ACD, GABARAP, APOA1, APOA2 
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Table 4.1 continued 
Gene name and 
symbol HOXA1 
 
Homeobox A1 
 
Alternative names 
Homeobox Protein Hox-A1, Homeobox Protein Hox-1F, HOX A1 Homeodomain 
Protein 
 
Cellular location of 
protein 
Nucleus 
 
Molecular function sequence-specific DNA binding transcription factor activity, protein binding, sequence-
specific DNA binding 
Molecular process 
 
transcription, DNA-dependent, regulation of transcription from RNA polymerase II 
promoter, multicellular organismal development, nervous system development, sensory 
perception of sound 
 
Cellular pathways 
 
Neural Crest Differentiation 
 
Protein domains 
Belongs to the Antp homeobox family. Labial subfamily, Contains 1 homeobox DNA-
binding domain 
 
Protein-protein 
interactions 
TRAPPC6A, EFEMP2, LPXN, PRNP, CHIC2 
 
 
 
 
 
Gene name and 
symbol UBE2H 
 
ubiquitin-conjugating enzyme E2H 
Alternative names 
 
UBE2H, Ubiquitin-Conjugating Enzyme E2H 
 
Cellular location of 
protein 
 
Molecular function 
ubiquitin-protein ligase activity, protein binding, ATP binding, acid-amino acid ligase 
activity 
 
Molecular process 
ubiquitin-dependent protein catabolic process, protein ubiquitination, protein K48-
linked ubiquitination, protein K11-linked ubiquitination 
 
Cellular pathways 
 
Ubiquitin mediated proteolysis/protein modification, protein ubiquination 
 
Protein domains 
 
Belongs to the ubiquitin-conjugating enzyme family 
 
Protein-protein 
interactions 
HIST2H2AA3, CD99, DTX3, MARCH2, MKRN3 
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Table 4.1 continued 
Gene name and 
symbol CNTNAP2 
 
contactin associated protein-like 2 
 
Alternative names 
Contactin-Associated Protein-Like, Homolog Of Drosophila Neurexin, NRXN4, 
AUTS15 
 
Cellular location of 
protein 
early endosome, Golgi apparatus, voltage-gated potassium channel complex, cell 
surface, membrane 
 
Molecular function receptor binding, protein binding, enzyme binding 
 
Molecular process cell adhesion, signal transduction, brain development, behaviour, neuron recognition 
 
Cellular pathways cell adhesion molecules 
 
Protein domains 
Belongs to the neurexin family,  Contains 2 EGF-like domains, Contains 1 F5/8 type C 
domain, Contains 1 fibrinogen C-terminal domain, Contains 4 laminin G-like domains 
 
Protein-protein 
interactions 
CASK, CNTN2, CTR9, ZMIZ1, KCNA2 
 
 
 
 
 
Gene name and 
symbol FZD9 
 
frizzled family receptor 9 
 
Alternative names Frizzled Homolog, Frizzled 9, Seven Transmembrane Spanning Receptor 
 
Cellular location of 
protein 
cytoplasm, plasma membrane, cell surface, membrane, integral to membrane, 
filopodium membrane, perinuclear region of cytoplasm 
Molecular function 
signal transducer activity, receptor activity, transmembrane signaling 
 
receptor activity, G-protein coupled receptor activity, protein binding, Wnt-protein 
binding, PDZ domain binding, protein homodimerization activity, Wnt-activated 
receptor activity, protein heterodimerization activity 
Molecular process 
 
vasculature development, cell surface receptor signaling pathway, nervous system 
development, neuroblast proliferation, brain development, learning or memory, gonad 
development, embryo development, B cell differentiation 
Cellular pathways  Wnt signaling pathway, Melanogenesis, Pathways in Cancer, Basal cell in carcinoma 
Protein domains 
 
G-protein coupled receptor Fz/Smo family, 1 FZ (frizzled) domain 
 
Protein-protein 
interactions 
MDFI, WNT2, WNT1, WNT7A, LRP6 
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Table 4.1 continued 
Gene name and 
symbol FZD1 
 
frizzled family receptor 1 
Alternative names Frizzled 1, Seven Transmembrane Spanning Receptor, Wnt Receptor 
Cellular location of 
protein 
cytoplasm, plasma membrane, cell surface, integral to membrane, synaptosome 
 
Molecular function 
 
receptor binding, protein binding, Wnt-protein binding 
 
Molecular process 
 
positive regulation of protein phosphorylation, vasculature development, membranous 
septum morphogenesis, muscular septum morphogenesis, outflow tract morphogenesis 
 
Cellular pathways 
 
Wnt signaling pathway, Melanogenesis, pathways in cancer, basal cell carcinoma 
Protein domains 
 
Lys-Thr-X-X-X-Trp motif interacts with the PDZ doman of Dvl (Disheveled) family 
members and is involved in the activation of the Wnt/beta-catenin signaling pathway,  
The FZ domain is involved in binding with Wnt ligands 
 
Protein-protein 
interactions 
DLG4, WNT4, GNAO1, WNT1, WNT2 
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4.6.2 Common transcription factors for the identified candidate genes on chromosome 7 
A list of transcription factors for each candidate gene was obtained via the Genecards ® 
database. The identified TFs were ranked based on the number of genes they regulate above 
75% of the genes. Finally, a list of ranked TFs was generated. 
 
Figure 4.3: The highest ranking transcription factors regulating candidate genes for Autism and ASDs  
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Chapter 5: DISCUSSIONS AND CONCLUSIONS 
5.1. SNP analysis 
Recent research has shown that hundreds of genetic variants – big, small, rare, common, 
inherited and spontaneous – along with environmental factors contribute to autism risk 
(Hughes 2013). In 2012, in a massive genome-wide association study, researchers identified 
57 SNPs associated with autism. The findings were presented at the International Meeting for 
Autism Research in 2012. The identified 57 SNPs predict with a high level of certainty that 
siblings of children with ASD have a higher risk of also developing the condition 
(Schellenberg et al., 2012). This study comprised of more than 1 000 multiplex families of 
which one or more children were diagnosed with ASD. These findings support an earlier 
study conducted by Carayol et al., (2011), where 8 autism-related SNPs were identified 
(Carayol et al., 2011). 
5.2. Genes ABCA13 and ABHD11 
While there has been no conclusive association for either ABHD11 or ABCA13 to autism and 
ASDs, strong association has been found for both for co-morbid disorders to autism and 
ASDs (Tordjmann et. al., 2012 and Stahlberg et. al., 2003). Co-morbid disorders for ABCA13 
include schizophrenia, bipolar disorder and major depression. ABHD11 has been implicated 
as a causative genetic factor for WBS. The development of this disorder is caused by the 
deletion of contiguous genes at the 7q11.23 position (Berg et al., 2007). The behavioural 
phenotype of WBS has been considered to be the polar opposite of ASD, but research 
suggests that common WBS deletions can result in a myriad of social communication 
impairments, such as excessive talkativeness and over friendliness, but also the absence of 
verbal language and poor social skills, which is a common phenotype displayed by 
individuals on the ASD spectrum (Tordjmann et al., 2012). The most common types of 
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structural variation in the human genome, CNVs (copy number variants) have been attributed 
to many genetic disorders associated with WBS (Merle et al., 2010). Some of these include 
cardiovascular and connective tissue abnormalities, growth and endocrine problems, 
neurological problems and cognitive and behavioural problems. 
The present study is the first to investigate the prevalence of ABHD11 and ABCA13 SNPs in a 
South African population across different ethnic groups. 
 
5.3. SNP rs10279013 and rs2293484 on ABHD11 
 
5.3.1. rs10279013 
The CC genotype was displayed at the highest frequency in the total South African 
population, across all ethnic groups. 98% of the autistic Caucasian group exhibited this 
genotype, with similarly high numbers in the other two ethnic groups (table 2.1). The TT 
genotype was not displayed in any of the groups, across the ethnic groups for healthy or 
autistic. The heterozygous CT genotype was found to be present in varying values; the 
autistic population exhibited low values between 2% and 14% whereas the healthy population 
had higher frequencies of this genotype, between 16% and 44%. The autistic Caucasian 
population showed a low frequency for the CT genotype at 2%. The highest frequency for 
this genotype was found in the healthy Mixed population, at 44%. The minor C allele for this 
SNP has been found in the East Asian, North African, Central African and West African 
populations (www.genecards.org). The statistical significance indicates that the CC genotype 
and C allele predisposes individuals in the Caucasian and Mixed groups to autism (table 2.1). 
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5.3.2. rs2293484 
In both the autistic and control groups, the G allele was displayed at the highest frequency by 
individuals in the South African population, across all the ethnic groups. The SA Caucasian 
groups displayed the highest number of individuals with the G allele, with the SA Mixed 
group showing the lowest number. Similar results have been shown in the Han Chinese and 
Japanese populations. The C allele was displayed in low numbers across all groups in the 
population (Knight et al., 2009) No significance for this SNP was found in any cohort studies 
with regards to autism and its’ associated disorders. 
5.4. SNP rs17060 on ABCA13 
5.4.1. rs17060 
In the SA total population, for rs17060, the C allele was dominant, displayed in more than 
60% of individuals in the autistic group and 70% in the healthy group. The T allele was 
displayed in very low numbers in both groups, with only 11% of individuals in the SA 
Caucasian group of the controls displaying it. The genotype and allelic frequencies has not 
yet been investigated in human populations for autism, and the statistical significance 
indicated in this study has found that in a South African healthy and autistic population, 
males with the T allele for rs17060 are more susceptible to autism. 
The present study provides evidence for not only the association of the investigated SNPs in a 
South African population, but could also allude to the co-morbidity of autism and WBS, as 
the ABCA13 gene is involved in the development of WBS.  
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5.5. Bioinformatics  
During the course of this study, a bioinformatics approach was used to identify and 
characterise novel candidate genes on chromosome 7 possibly involved in Autism and ASDs. 
Candidate genes were identified from a previous study and two additional new candidate 
genes were identified using the STRING database by using existing candidate genes and 
searching for available networks and interactions with other genes. 
5.5.1. New candidate genes FZD1 and FZD9 
Both new, additional FZD1 and FZD2 genes that were identified using the STRING database 
are members of the “frizzled”gene family. Members of this gene family encode 7-
transmembrane domain proteins that are receptors for Wnt signaling proteins. Of the 19 new 
potential candidate genes that were identified from STRING analysis, FZD1 and FZD9 were 
the only two genes located on chromosome 7, which made them suitable candidates for 
further investigation as to their properties and possible involvement in ASD and co-morbid 
disorders. 
FZD1 is located at chromosomal position 7q21, and contains a single peptide; a cysteine-rich 
domain in the N-terminal extracellular region, 7 transmembrane domains, and a C-terminal 
PDZ domain-binding motif. The FZD1 transcript is expressed in various tissues.  
 
Figure 5.1: Red line indicates the position of the FZD1 gene on chromosome 7 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD1) 
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The FZD1 gene has been implicated in regulating chemo-resistance for cancer treatment 
(Flahaut et al., 2009). In the 2009 study, FZD1 upregulation in resistant variants was shown 
to mediate and sustain activation of the Wnt/ß-catenin pathway. During this process, a strong 
decrease was seen in the expression of MDR1 – another ß-catenin target gene – revealing a 
complex interaction, implicating FZD1 in clinical chemoresistanc via the Wnt/ß-catenin 
mediation. Wnt receptors have been shown to play a role in the development of human cancer 
(Sagara et al., 1998) by the regulation of ß-catenin pathways and FZD1 mRNA is found to 
populate a significant amount of human tissue, including the adult heart, placenta, lung, 
kidney and fetal kidney.  ß-catenin mutation is also detected in some cases of gastric cancer, 
coclorectal cancer, ovarian cancer and endometrial uterus cancer (Kawanishi et al., 1995, 
Rubinfeld et al., 1994, Palacios and Gamallo 1998 and Fukuchi et al., 1998). Another study 
implies that the Wnt/Fzd signaling pathway specificity is reliant on the subcellular 
localization of the FZD genes, through association with other membrane proteins (Jun et al., 
2004). They have found that the subcellular localization difference contributes directly to the 
signalling specificity outcome. The FZD1 gene has not previously been implicated in ASD or 
related disorders. 
The FZD9 gene is located within the Williams syndrome common deletion region of 
chromosome 7 and heterozygous deletion of the FZD9 gene may contribute to the Williams 
syndrome phenotype. FZD9 is expressed predominantly in brain, testis, eye, skeletal muscle, 
and kidney (http://www.ncbi.nlm.nih.gov/gene/8326). As previously mentioned in this work, 
WBS is a rare neurodevelopmental disorder that is characterised by an elfin facial 
appearance, a low nasal bridge, an unusually cheerful demeanour and ease with strangers, as 
well as developmental delays, strong language skills and cardiovascular problems (Berg et 
al., 2007). 
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Figure 5.2: Red line indicates the position of the FZD9 gene on chromosome 7 
(http://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD9&keywords=FZD9)  
FZD9 gene is selectively expressed in the hippocampus throughout life with a strong 
expression in the neuroepithelium. Fzd9 null heterozygous mice have increased apoptotic cell 
death and increased precursor proliferation during hippocampus development. Moreover, 
Fzd9 mutants exhibit defects in learning and memory, reflecting hippocampus functional 
deficits.30 Overall, these evidences point out that Fzd9 has an important role in hippocampus 
development, and therefore, Fzd9 may be an intriguing candidate for the neurodevelopmental 
and behavioral phenotype of WBS individuals. Overall, these observations suggest that 
BAZ1b and FZD9 remain two good candidate genes for the facial features and 
neurodevelopmental phenotype of WBS patients, respectively (Fusco et al., 2014). 
5.5.2. Frizzled genes and the Wnt2 pathway 
 
Figure 5.3: Schematic representation of the canonical Wnt2 pathway (Nelson and Nusse, 2004) 
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 Figure 5.3 shows the Wnt signal transduction cascade. An estimated 19 Wnt members exist 
in mammals, and these act as sort range ligands to activate receptor-mediated signalling 
cascades (Nelson and Nusse, 2004). Proteins which act as cell surface receptors for Wnts are 
called 'frizzled' and the FZD family of genes is directly involved in this process. Activated 
frizzled receptors connect to several downstream pathways. 
Wnt2 activates the 7-transmembrane-spanning Fzd9 receptor, which together with the co-
receptor LRP5/6 activates dishevelled (DVL). Activated DVL inhibits the activity of the β-
catenin “destruction complex” (indicated as a light blue ellipse). β-catenin is released from its 
complex with cadherin by the activity of the HGF receptor MET. When β-catenin is protected 
against destruction, it can enter the nucleus, bind the transcription factor LEF1 and co-factors 
to promote transcription of target genes like, for example, engrailed 2 (EN2). The functional 
consequence is an increase in cell growth and motility (Kalkman, 2012). The canonical Wnt 
pathway plays an important role in brain development (Galceran et al., Zhou et al., 2004, Lie 
et al., 2005 and Rosso et al., 2005) and synaptic function (Krylova et al., 2002, Packard et 
al., 2002 and Chen et al., 2006). It is for these reasons that mutations in the Wnt pathway are 
implicated in ASDs and indeed psychiatric disorders in general. 
5.6. Transcription factors and candidate genes 
Because transcription factors essentially initiate and control the regulation of genes, we 
thought it important to look at the commonality of transcription factors (TFs) across the 
candidate genes on chromosome 7. This might lead to clues about pathways that are common 
or might overlap between genes that confer phenotypical attributes, but may not necessarily 
be associated with autism and ASDs. For example, mutations in exon 2 of the GATA1 TF are 
present in almost all cases of Down-Syndrome associated transient myeloproliferative 
disorder or transient leukemia (Wechsler et al., 2003). We see from our Genecards ® data-
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gathering that GATA1 TF is involved in the regulation of all the candidate genes from our 
STRING network, and we know that Down-Syndrome is present as a co-morbid disorder for 
any ASD cases. The CUTL1 TF, which is a homeodomain protein that is involved in gene 
expression, morphogenesis, and differentiation, also plays a role in cell-cycle progression 
(Nepveu, 2000). Genetic data from over 7,600 cancer patients shows that over 1% has the 
deactivated CUX1 which links to progression of tumour growth (Wong et al., 2014). 
In recent years, more and more genetic evidence has become available that points to a link 
between cancer and autism. According to a 2013 study at the University of Washington, 10% 
of children with mutations in a gene called PTEN –associated with breast, colon and thyroid 
cancer, among others-have autism. As with all genetic disorders, not everyone with the 
mutation develops autism or cancer, or any other neurological diseases or disorders. The 
findings have only been seen in a small test population thus far. It was Dr. Charis Eng, a 
cancer geneticist at the Cleveland Clinic, who first noticed a surprising incidence of autism in 
children whose parents had the PTEN mutation (pronounced p-10). Eventually, investigators 
discovered that the rate of autism was 10 percent, about 10 times what would normally be 
expected. At the same time, researchers found that another genetic disorder was even more 
likely to result in autism. That disorder, tuberous sclerosis, increases the risk for kidney 
cancer and a type of brain cancer; half of tuberous sclerosis patients had autism. 
Although PTEN and tuberous sclerosis genes are not the same, they are part of the same 
network of genes that halt or hamper cell growth. Disabling PTEN or one of the tuberous 
sclerosis genes reactivates cell growth. One result can be cancer or tumours. Another can be 
abnormal wiring of nerve fibres in the brain and autism. In families with no genetic history of 
autism, it was found that autistic children had two to three times as many mutations that 
disabled a gene than their parents or siblings. These mutated genes were often involved in 
pathways that controlled cell growth. As seen in the results of this study, the FDZ genes are 
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significantly involved in Wnt pathway, which is in turn involved in cellular growth. The other 
candidate genes that have been investigated and summarized via the GeneCards database 
shows significant involvement in cell growth, pathways in cancer and influences on 
neurological function at a molecular level. 
The bioinformatics methods used here have effectively shown the interconnectivity of genes 
on chromosome 7; indicating that common pathways and common transcription factors, as 
well as close proximity on the chromosome plays a role in the implication of these candidate 
genes in autism and related disorders. An even more surprising genetic link was found 
between cancer and autism, and as indicated in the literature review by Crespi in 2011, the 
genetic overlap between cancer and autism allows for further research into looking at more 
well-known cancer genes. Pharmalogical therapies that help to alleviate cancer symptoms 
might also be employed in the treatment of autism (Crespi, 2011). 
5.7. Future studies 
While the causes of autism are unclear, it is the general consensus that the causative factors of 
the disorder are linked to both environment and genetics. While the MMR vaccine theory has 
been completely ruled out now, other factors such as mercury levels in food, difficult 
pregnancies and viral infections have been reported as causative factors for autism and ASDs. 
These factors, along with strong evidence for a clear genetic link have illuminated the causes 
for the disorder. By researching the genetic factors of a disorder, it allows health care 
practitioners, teachers, parents and guardians to make better, informed decisions as to the 
treatment and care for individuals with autism and ASDs. Epigenetic studies will assist in the 
eventual development of specialized medication tailored to an individual’s unique genetic 
makeup. One of the biggest problems experienced by children with ASD is ‘leaky gut 
syndrome’; in which the gastrointestinal system and thus the diet is compromised by 
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inflammation in the bowel linings. A 2013 study has shown that incorporating certain doses 
of a human gut microbe in mice with autism-like symptoms helped reverse behavioural 
problems in these mice (Hsiao et al., 2013).This treatment also reduced gastrointestinal 
problems in the mice that were similar to those seen in humans with autism. Future studies 
may make use of different methods of high throughput SNP detection such as DHPLC, 
sequencing by hybridization and UNG-mediated T-sequencing (Kwok and Chen, 2003). 
Further studies can look at family cohort studies to investigate the hereditary pattern of 
autism across generations and may be able to predict the possibility of predisposition for 
autism in future generations. With the major advances being made in medical science and 
development of the Human Genome Project, the possibility of personalized medicine 
becomes an option for individuals with specific needs who are on the Autism spectrum. 
Bionformatics results have yielded in two new candidate genes to look at for this study and 
can thus be further employed to continue to search pools of genes for more candidate genes. 
Employing computational methods in an era when overwhelming amounts of data is gleaned 
from traditional lab practices will only serve to aid in a better understanding – and 
organization – of said data. 
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GLOSSARY 
Allele frequency – Allele frequency is the number of copies of a particular allele divided by 
the number of copies of all alleles at the genetic place (locus) in a population. It can be 
expressed for example as a percentage. In population genetics, allele frequencies are used to 
depict the amount of genetic diversity at the individual, population, and species level. 
Autism Spectrum Disorder - Autism spectrum disorder (ASD) and autism are both general 
terms for a group of complex disorders of brain development. These disorders are 
characterized, in varying degrees, by difficulties in social interaction, verbal and non-verbal 
communication and repetitive behaviours. With the May 2013 publication of the DSM-5 
diagnostic manual, all autism disorders were merged into one umbrella diagnosis of ASD. 
Bioinformatics - an interdisciplinary field that develops methods and software tools for 
understanding biological data. As an interdisciplinary field of science, bioinformatics 
combines computer science, statistics, mathematics, and engineering to analyze and interpret 
biological data. 
Candidate genes - A candidate gene is a gene located in a chromosome region suspected of 
being involved in the expression of a trait such as a disease, whose protein product suggests 
that it could be the gene in question. 
Chromosomal hotspot – chromosomes in the genome that carry a significant amount of 
candidate genes that have been positively linked to a particular disease or disorder. 
Chromosome 7 - spans about 159 million base pairs and represents between 5 and 5.5 
percent of the total DNA in cells. 
Epigenetics - the study, in the field of genetics, of cellular and physiological phenotypic trait 
variations that are caused by external or environmental factors that switch genes on and off 
and affect how cells read genes instead of being caused by changes in the DNA sequence. 
Genotype - The genotype is the genetic constitution of a cell, an organism, or an individual 
(i.e. the specific allele makeup of the individual) usually with reference to a specific character 
under consideration. 
Hardy-Weinberg equation - The Hardy–Weinberg principle states that both allele and 
genotype frequencies in a population remain constant—that is, they are in equilibrium—from 
generation to generation unless specific disturbing influences are introduced. Those 
disturbing influences include non-random mating, mutations, selection, limited population 
size, "overlapping generations", random genetic drift and gene flow.   
Heterozygous - Having different alleles at one or more corresponding chromosomal loci. 
Homozygous - Having the same alleles at a particular gene locus on homologous 
chromosomes. 
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Human Genome Project - an international scientific research project with the goal of 
determining the sequence of chemical base pairs which make up human DNA, and of 
identifying and mapping all of the genes of the human genome from both a physical and 
functional standpoint. 
Neurodevelopmental disorders – Severe disabling conditions often associated with life-long 
impairment and are recognized to be the result of abnormalities in brain development due to 
both genetic and environmental/biological causes. 
Polymerase Chain Reaction - In molecular biology, the polymerase chain reaction (PCR) is 
a technique to amplify a single or few copies of a piece of DNA across several orders of 
magnitude, generating thousands to millions of copies of a particular DNA sequence. 
Single nucleotide polymorphism – frequently called SNPs, these are the most common type 
of genetic variation among people (e.g. 1%) in which a single nucleotide in the genome (or 
other shared sequence) differs between members of a biological species or paired 
chromosomes. 
Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) - a wide-ranging 
visual database that assimilates information on known and predicted protein interaction. It 
offers a unique visual representation of very specific protein-protein interaction networks, 
which can be manipulated by adding more proteins, taking them away or changing their 
positioning within the network. 
Transcription factor - a protein that binds to specific DNA sequences, thereby controlling 
the rate of transcription of genetic information from DNA to messenger RNA. 
Williams Syndrome - a multi-system developmental disorder caused by the deletion of 
contiguous genes at the 7q11.23 position. It is a rare neurodevelopmental disorder that is 
characterised by an elfin facial appearance, a low nasal bridge, an unusually cheerful 
demeanour and ease with strangers, as well as developmental delays, strong language skills 
and cardiovascular problem. 
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Private Bag X17, Belvil le, 7535 
South Africa 
Tel: +27 (0) 21 959 2215 
Fax: +27 (0) 21 959 3505 
Website: www.uwc.ac.za Appendix I: Cover letter 
 
Department of Biotechnology 
 
June/July 2011 
 
Dear parents/ guardians 
I am lecturing in the Biotechnology Department at the University of the Western Cape.  I am currently 
heading a project which examines the genetics of Autism in a South African population. A study of 
this type has not been undertaken in South Africa but has been extensively done in other countries. We 
anticipate the results from this study will aid the understanding of genetics as a cause of Autism. 
The project was started in 2005 and is ongoing. Some parents have already consented and have 
participated in the study but we require new and more samples because we are doing additional 
genetic investigations. Our research has generated one scientific paper in 2008 and we have presented 
our research at the Autism Conference in 2006 at the Convention Centre Cape Town. Our more recent 
research was presented at the joint Africa-South Africa Human Genetics Society Conference in 2011. 
We welcome additional participants to the project and any families that are interested in family studies 
are most welcome. 
In order to do this study, we need your consent to obtain information and biological material from you 
and your children. The biological material will be obtained from the scholars by collecting cheek cells 
from the inside of the mouth, using a swab. It is a painless and non-intrusive procedure. The whole 
procedure will only take a few minutes and will be done by properly trained individuals under 
hygienic conditions in their respective classroom in the presence of their teacher. 
The project has been approved by the principal and the UWC Ethics Committee. I am most willing to 
meet with you and discuss the project. Please fill in the attached consent form and return the form 
to the school promptly; if you have consented previously, we need you to complete the form 
again for ethical reasons. 
 
Yours in anticipation 
………………………………… 
Dr. Zainunisha Arieff 
021 959 2214 
zarieff@uwc.ac.za 
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Appendix II: Consent form 
Clearly print:           Full name of child…………………………………………….. 
            Date of birth …………………………………………………… 
            Grade ………………………………………………………….. 
          School…………………………………………………………. 
 
Please indicate with a cross on the slip, the option which you have chosen.  
 
Option 1:    I hereby give permission for my child to be included in this research. 
 
Option 2:    I would like to have more information.    
 
Option 3      I do not give permission for participation in this research.   
 
If you have chosen option 1, please read and fill in the form below: 
 
1. I, ____________________________________________, consent to the use of my childs’ genetic 
material in the study outlined above.  
2.  I understand that the genetic material for analysis is to be obtained from blood and urine samples 
that I will donate. 
3. I understand that the sample has been assigned a unique identification number and that there will 
be no link between my child’s name and the unique identification number. 
4  Since the sample has been collected anonymously it cannot be withdrawn from the study.   
5 The sample will be stored indefinitely. 
6 The results of the project will be published in a scientific journal. 
7. The analysis procedure only provides information on variable genetic elements on specific 
chromosomes and cannot determine the complete genetic makeup of an individual.  
8. At no stage will the sample provided be used for anything other than the analysis of biomolecules 
involved in autism. 
9. ALL OF THE ABOVE HAS BEEN EXPLAINED TO ME IN A LANGUAGE THAT I 
UNDERSTAND AND MY QUESTIONS ANSWERED BY: 
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Dr Zainunisha Arieff 
Senior Lecturer 
Dept of Biotechnology 
Email: zarieff@uwc.ac.za 
Tel: (021) 9592214/5 
 
Parent’s/Guardian’s signature: __________________________________ 
 
     Contact number(s):___________________________________________ 
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Appendix III: Background of Project  
Title of project: Genetics of Autism in South Africa 
 
Autism, also known as the autistic spectrum disorder (ASD) or pervasive developmental disorder 
(PDD) is a complex, behavioral defined disorder of the immature brain.  
There are 5 different sub-types of autism (Classic autism, Asperger disorder, disintegrated disorder, 
PDD – pervasive developmental disorder and Rett syndrome). It was shown using genetic tools that 
each sub-type is linked to one or more chromosomal regions (Muhle et al. 2004). To date, a minimum 
of 15 genes have been linked to this disorder (Yonan et al. 2003). Since autism has such a broad 
clinical spectrum, a genetic study will aid the understanding of the genes involved in the cause of the 
disorder. Thus far genetic research has been shown that specific genes and/or chromosomal regions 
have been associated with these disorders (Muhle et al. 2004, Wassink et al. 2004). 
 
Although numerous clinical investigations have been performed on autism in South Africa, no articles 
have been published on genetic studies. For this reason the genetics group at UWC would like to 
investigate the possible causative genes, or to identify biomarkers involved in autism. To perform this 
type of research, we will require biological material such as cheek swabs and/or blood/urine from the 
children at the school, the unaffected children and the parents. This cannot be done without the written 
consent of the parents or guardians and the committee. In addition; the consent of the afore-mentioned 
bodies will support our application to the UWC Ethics Committee. The application is registered with 
the UWC Ethics committee and research funding has been acquired for this type of research. 
 
The reasons for undertaking this type of research project are as follows: 
(a) Genetic diagnosis and treatment – earlier diagnosis would lead to earlier treatment/therapy of 
affected children. The affected individuals will therefore be able to develop to their full potential with 
the proper treatment and therapy. Genetic studies will also allow us to establish the pathways which 
are affected in the disorder. 
 
(b) Education and awareness of the genetic causes of the disorder. Education of disorder will 
remove the stigmatism associated with the disorder and more awareness could lead to greater funding 
being steered in the direction of this type of research. The awareness will also allow us to estimate the 
real incidence of the disorder in the various communities in South Africa. 
 
(c) South African research in a global context – many genetic studies has been performed in the 
USA and UK but none on affected South African individuals. Our team will publish and present the 
research findings at both local and international conferences. 
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